Back to top

Image: Bigstock

4 Top Sectors of Last Week & Their Winning ETFs

Read MoreHide Full Article

Last week was moderate for Wall Street with the S&P 500, the Dow Jones and the Nasdaq returning about 3%, 2.2% and 6.1%, respectively. Wall Street staged a relief rally on hopes of reopening of American businesses, an improving virus outlook and chances of treatment coming on stream. Wall Street gained despite downbeat data in the field of industrial production, retail sales and homebuilder confidence (read: Order Cancellations Weigh On Housing ETFs: What Lies Ahead?).

Government’s and the Fed’s unprecedented stimulus to support the economy also had the markets charged up. On Apr 17, the United States announced $19 billion of coronavirus aid for farmers and food purchases for the needy. No doubt, recessionary fears are largely due to widespread lockdowns globally. But the virus scare and lockdowns have raised demand for some specific investing areas this time around.

Against this backdrop, below we highlight a few sector ETFs that topped Wall Street last week.

Technology

This is one of the sturdiest sectors amid the coronavirus outbreak as social distancing boosted demand for work-from-home, cloud computing, video gaming, streaming, and online payments. The growing adoption of 5G technology — the next wireless revolution — is opening up further opportunities. Internet stocks have all the more reason to stay safe as it has less to do with human contact (read: Amid The Tech Slump, Internet ETFs Most Resilient To Virus).

MicroSectors FANG+ ETN FNGS (up 11.2%), ARK Innovation ETF (ARKK - Free Report) (up 10.5%), Invesco DWA Technology Momentum ETF (PTF - Free Report) (up 10.1%) and WisdomTree Cloud Computing Fund WCLD (up 9.9%) were the prominent winners.

Healthcare

Development in the area of antibody treatment and vaccine has been encouraging. Gilead Sciences’ (GILD - Free Report) antiviral medicine remdesivir is receiving positive response in clinical trials in some COVID-19 patients. Plus, Abbott (ABT - Free Report) has launched its third COVID-19 test. Then there are healthcare giants like Johnson & Johnson (JNJ - Free Report) which are trying to come up with a vaccine. (read: Biotech Stocks, ETFs To Gain On COVID-19 Vaccine & Drug Progress).

In short, the ongoing medical emergency has brightened the sector’s prospects pretty much. No wonder, ARK Genomic Revolution Multi-Sector ETF (ARKG - Free Report) (up 12.3%), iShares Genomics Immunology and Healthcare ETF IDNA (up 10.9%), VanEck Vectors Biotech ETF (BBH - Free Report) (up 10.5%) and Loncar Cancer Immunotherapy ETF (CNCR - Free Report) (up 10.5%) gained materially last week.

MLPs

With demand sinking and supply overflowing, energy companies are now looking only for storage — something that global oil producers and refiners are running short of. However, while oil prices slumped to as low as $18 last week, MLPs were not in that bad a position. This is because MLPs earn profits from the quantity of oil and natural gas they are transporting. Plus, MLPs are high-dividend in nature. ETRACS Alerian MLP Index ETN (up 9.9%), Alerian MLP ETF (AMLP - Free Report) (up 9.6%) and Global X MLP ETF (MLPA - Free Report) (up 9.4%) were the winners.

e-Commerce

Social distancing amid growing fears of virus contamination has been aiding the space. Though U.S. retail sales slumped in March, non-store retail trade in March rose 3.1% sequentially and 9.7% year over year. (read: Is Coronavirus a Boon for Online Retail ETFs?).

Online orders have jumped 80% in North America since January. Not only in the United States, lockdowns are benefiting complete c-Commerce brands in Europe too. Adobe Analytics indicated a 25% surge in average U.S. daily online sales in Mar 13-15 compared with Mar 1-11. Since March data was bullish, investors can expect gains in online sales in the peak of lockdown.

Global X E-commerce ETF EBIZ (up 9%), Amplify Online Retail ETF (IBUY - Free Report) (up 8.8%), ProShares Long Online/Short Stores ETF CLIX (up 8.8%), and ProShares Online Retail ETF ONLN (up 8.3%) were the winners.

Want key ETF info delivered straight to your inbox?

Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>

Published in